ATE190487T1 - Granuläre zubereitung - Google Patents

Granuläre zubereitung

Info

Publication number
ATE190487T1
ATE190487T1 AT93923650T AT93923650T ATE190487T1 AT E190487 T1 ATE190487 T1 AT E190487T1 AT 93923650 T AT93923650 T AT 93923650T AT 93923650 T AT93923650 T AT 93923650T AT E190487 T1 ATE190487 T1 AT E190487T1
Authority
AT
Austria
Prior art keywords
administration
pharmaceutical preparation
preparation
granular pharmaceutical
tube
Prior art date
Application number
AT93923650T
Other languages
English (en)
Inventor
Hiroaki Nakagami
Taketoshi Keshikawa
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Priority claimed from PCT/JP1993/001553 external-priority patent/WO1995011674A1/ja
Application granted granted Critical
Publication of ATE190487T1 publication Critical patent/ATE190487T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93923650T 1993-10-27 1993-10-27 Granuläre zubereitung ATE190487T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001553 WO1995011674A1 (en) 1992-04-28 1993-10-27 Granular preparation

Publications (1)

Publication Number Publication Date
ATE190487T1 true ATE190487T1 (de) 2000-04-15

Family

ID=14070606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923650T ATE190487T1 (de) 1993-10-27 1993-10-27 Granuläre zubereitung

Country Status (6)

Country Link
US (1) US6335036B1 (de)
AT (1) ATE190487T1 (de)
DE (1) DE69328128T2 (de)
DK (1) DK0729756T3 (de)
ES (1) ES2145065T3 (de)
RU (1) RU2143898C1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003077886A1 (en) * 2002-03-20 2003-09-25 Hosokawa Micron Corporation Method of manufacturing chemical-containing composite particles
RU2406499C2 (ru) * 2005-05-17 2010-12-20 Сантен Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство для лечения кератоконъюнктивитных нарушений
RU2375929C2 (ru) * 2008-02-07 2009-12-20 Александр Александрович Емельянов Способ получения сухого сока
JP5503879B2 (ja) * 2008-02-28 2014-05-28 参天製薬株式会社 視神経障害を伴う眼疾患の予防又は治療剤
RU2435572C1 (ru) * 2010-10-22 2011-12-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Ставропольский государственный аграрный университет" Антиоксидантный препарат для животных
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP4536191A1 (de) * 2022-06-06 2025-04-16 Sound Pharmaceuticals Incorporated Ebselen enthaltende orale darreichungsformen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3027075A1 (de) 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3226284A1 (de) 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
DE3407511A1 (de) 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
JPH0755905B2 (ja) 1986-07-17 1995-06-14 第一製薬株式会社 肝臓疾患治療剤
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
JPS6413522A (en) 1987-07-08 1989-01-18 Ricoh Kk Liquid crystal display device
DE3821392A1 (de) 1988-06-24 1989-12-28 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)
DE3827093A1 (de) * 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
US5288734A (en) * 1988-10-29 1994-02-22 A. Nattermann & Cie Gmbh Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
ES2177849T3 (es) * 1996-08-27 2002-12-16 Nattermann A & Cie Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.

Also Published As

Publication number Publication date
US6335036B1 (en) 2002-01-01
DE69328128D1 (de) 2000-04-20
ES2145065T3 (es) 2000-07-01
RU2143898C1 (ru) 2000-01-10
DE69328128T2 (de) 2000-08-24
DK0729756T3 (da) 2000-06-05

Similar Documents

Publication Publication Date Title
ES2075338T3 (es) Formulacion de naproxeno, de absorcion controlada, para administracion una vez al dia.
ES8604020A1 (es) Un procedimiento para la obtencion de polimeros porosos reticulados para liberacion controlada de farmacos
ES2064564T3 (es) Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
FI924247A0 (fi) En doseringsform foer frigoerande av medicin till tarmen.
MY102459A (en) Oral sustained release pharmaceutical preparation.
Quercia et al. Stability of omeprazole in an extemporaneously prepared oral liquid
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ZA912793B (en) Pharmaceutical formulations
NO924104D0 (no) Pulverformulering med flytekontrollert avgivelse
ATE43497T1 (de) Pharmazeutische formulierung mit gesteuerter absorption.
DE69328128D1 (de) Granuläre zubereitung
ES445014A1 (es) Procedimiento de obtencion de preparaciones farmaceuticas noamargas, para la administracion oral.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE3860967D1 (de) Arzneimittel in form stabiler suspendiermittel freier sucralfat-suspensionen.
DE69008107D1 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
KOMATSU et al. Biopharmaceutical evaluation of gelatin microcapsules of sulfonamides
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
EP0729756A4 (de) Granuläre zubereitung
RU96110213A (ru) Гранулированный фармацевтический препарат
KR870010082A (ko) 구아르(guar) 분말
GB1219026A (en) Tablet preparation
Nelson et al. Respite care for the severely disabled child
TH26552A (th) วิธีการรักษา
Shidore et al. EFFECT OF AMMONIUM CHLORIDE AND SODIUM BICARBONATE ON PHARMACOIUNETICS OF THREE SULFONAMIDES
SE8505034D0 (sv) Kropp bestaende av en kerna med ett overdrag

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee